Journal of the Chinese Medical Association
Volume 72, Issue 4 , Pages 179-182, April 2009

Neoadjuvant Concurrent Chemoradiotherapy in Treating Locally Advanced Rectal Cancer

Division of Colorectal Surgery, Department of Surgery, Taichung Veterans General Hospital, Taichung, Taiwan, R.O.C.

Received 28 January 2008; accepted 12 March 2009.

Article Outline

Background

Colorectal cancer is a common cancer and a major cause of morbidity and mortality worldwide. Middle to lower rectal cancer, a challenge for surgeons, is problematic. Neoadjuvant concurrent chemoradiotherapy (CCRT), introduced in the last decade, leads the local control of advanced rectal cancer to a high percentage of R0 resection (margin negative under microscopic examination) and a low recurrence rate.

Methods

From January 2005 to June 2007, 46 patients with locally advanced rectal cancer who received neoadjuvant CCRT were included. Factors including disease-free survival time, overall survival time, local recurrence, metastasis, and postoperative complications were evaluated retrospectively. Response was defined according to Mandard's classification, in which TRG1 is no residual tumor and TRG2–3 is 50–100% tumor shrinkage.

Results

In this series, 3 patients who did not receive post-CCRT curative resection were excluded. The remaining 43 patients (22 males, 21 females) had received curative surgery and were included. Thirty-four patients had tumor shrinkage, and the response rate was 79% (Mandard's classification: TRG1–TRG3). The median follow-up time was longer than 1.5 years. Patients who responded to CCRT had lower local recurrence rates (5.9% vs. 55.6%; p = 0.002) and a greater curative resection rate (97.1% vs. 66.7%; p = 0.024). The complication rates of both groups were similar.

Conclusion

Neoadjuvant CCRT gives locally advanced rectal cancer patients a more favorable result, with acceptable toxicity.

Key Words:  locally advanced rectal cancer , neoadjuvant concurrent chemoradiotherapy , R0 resection

No full text is available. To read the body of this article, please view the PDF online.

 

Back to Article Outline

References 

  1. Miles WE . A method for performing abdomino-perineal excision for carcinoma of the rectum and the terminal portion of the pelvic colon . Lancet . 1908;ii:1812–1813
  2. Miles WE . Cancer of the Rectum . London: Harrisons; 1926;
  3. Surtees P , Ritchie JK , Phillips RK . High versus low ligation of the inferior mesenteric artery in rectal cancer . Br J Surg . 1990;77:618–621
  4. Harnsberger JR , Vernava VM , Longo WE . Radical abdominopelvic lymphadenectomy: historic perspective and current role in the surgical management of rectal cancer . Dis Colon Rectum . 1994;37:73–87
  5. Heald RJ , Husband EM , Ryall RD . The mesorectum in rectal cancer surgery: the clue to pelvic recurrence? . Br J Surg . 1982;69:613–616
  6. Kapiteijn E , Marijinen CAM , Colenbrander AC . Local recurrence in patients with rectal cancer diagnosed between 1988 and 1992: a population-based study in the west Netherlands . Eur J Surg Oncol . 1998;24:528–535
  7. Wolpin BM , Meyerhardt JA , Mamon HJ , Mayer RJ . Adjuvant treatment of colorectal cancer . CA Cancer J Clin . 2007;57:168–185
  8. Marks G , Mohiuddin M , Rakinic J . New hope and promise for sphincter preservation in the management of cancer of the rectum . Semin Oncol . 1991;18:388–398
  9. Frykholm GJ , Glimelius B , Pahlman L . Preoperative or postoperative irradiation in adenocarcinoma of the rectum: final treatment results of a randomized trial and an evaluation of late secondary effects . Dis Colon Rectum . 1993;36:564–572
  10. Valenti V, Hernandez-Lizoain JL, Baixauli J, Pastor C, Aristu J, Diaz-Gonzalez J, et al  Analysis of early postoperative morbidity among patients with rectal cancer treated with and without neoadjuvant chemoradiotherapy . Ann Surg Oncol . 2007;14:1744–1751

PII: S1726-4901(09)70050-4

doi:10.1016/S1726-4901(09)70050-4

Journal of the Chinese Medical Association
Volume 72, Issue 4 , Pages 179-182, April 2009

Article Tools